MARATTO

article · European Journal of Medicinal Chemistry

One destination, three routes: Tacrine-Celecoxib hybrids targeting cholinesterases, COX-2, and carbonic anhydrases in cognitive impairment linked to metabolic dysfunction

2026Alexandria University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Cholinesterase and Neurodegenerative Diseases
  • Enzyme function and inhibition
  • Nicotinic Acetylcholine Receptors Study

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher siteRecord on OpenAlex

DOI: 10.1016/j.ejmech.2026.118984

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

Sign in to join the discussion

New to MARATTO™? Create a free account.